Lilly, 3rd-Party Payors Reach $4.5M Deal In Zyprexa Case

Law360, New York (January 12, 2012, 7:28 PM EST) -- Eli Lilly & Co. secured approval Thursday of a $4.5 million settlement of claims brought by an insurer and five union health funds claiming they overpaid for the blockbuster antipsychotic drug Zyprexa because Lilly didn't reveal its adverse side effects.

U.S. District Judge Jack Weinstein approved the $4.5 million deal at a hearing in New York federal court Thursday, according to Lilly, which said that the settlement amount represented just a fraction of the estimated damages that the third-party payors had sought.

The third-party payor litigation...
To view the full article, register now.



Case Information

Case Title

In re: Zyprexa Products Liability Litigation

Case Number



New York Eastern

Nature of Suit

Personal Inj. Prod. Liability


Jack B. Weinstein

Date Filed

April 19, 2004

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.